Registry-based trials: a potential model for cost savings?.
Anderson, BR; Gotlieb, EG; Hill, K; McHugh, KE; Scheurer, MA; Mery, CM; Pelletier, GJ; Kaltman, JR; White, OJ; Trachtenberg, FL; et al.
Cardiology in the Young.
2020;
30:807-817.
Angiotensin-Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC-QIC Registry.
Hansen, JE; Brown, DW; Hanke, SP; Bates, KE; Tweddell, JS; Hill, G; Anderson, JB.
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.
2020;
9.
Resource utilisation in paediatric patients with secundum atrial septal defects.
Ziebell, DS; Ghaleb, S; Anderson, J; Statile, CJ.
Cardiology in the Young.
2020;
30:383-5.
Wearable cardioverter-defibrillators in pediatric cardiomyopathy: A cost-utility analysis.
Evers, PD; Anderson, JB; Ryan, TD; Czosek, RJ; Knilans, TK; Spar, DS.
Heart Rhythm.
2020;
17:287-293.
Enhancing efficiency and scientific impact of a clinical trials network: The Pediatric Heart Network Integrated CARdiac Data and Outcomes (iCARD) Collaborative.
Pasquali, SK; Kaltman, JR; Gaynor, JW; McCrindle, BW; Newburger, JW; Anderson, BR; Scheurer, MA; Pinto, NM; Anderson, JB; Oster, ME; et al.
Cardiology in the Young.
2019;
29:1121-1126.
Quality Improvement in Congenital Cardiac Disease.
Anderson, J; Verghese, G; Lihn, S; Tweddell, JS; Bates, KE; Rebolledo, M; Lannon, C. In: Wernovsky G; Anderson RH; Krishna K; Mussato KA; Redington A; Tweddell JS; Tretter J, Ed.
Anderson's Pediatric Cardiology.
Philadelphia, PA: Elsevier;
2019.
Can noninvasive testing identify benign patterns of suggested pre-excitation on electrocardiogram?.
Robinson, JA; Anderson, JB; Knilans, TK; Spar, DS; Czosek, RJ.
Pacing and Clinical Electrophysiology.
2019;
42:904-909.
Development of a System to Measure and Improve Outcomes in Congenital Heart Disease: Heart Institute Safety, Quality, and Value Program.
Clarke-Myers, K; Cooper, DS; Hanke, SP; Storey, J; McDonald, M; Kimball, TR; Anderson, JB.
The Joint Commission Journal on Quality and Patient Safety.
2019;
45:495-501.
Prenatal heart block screening in mothers with SSA/SSB autoantibodies: Targeted screening protocol is a cost-effective strategy.
Evers, PD; Alsaied, T; Anderson, JB; Cnota, JF; Divanovic, AA.
Congenital Heart Disease.
2019;
14:221-229.
Cardiac Networks United: an integrated paediatric and congenital cardiovascular research and improvement network.
Gaies, M; Anderson, J; Kipps, A; Lorts, A; Madsen, N; Marino, B; Costello, JM; Brown, D; Jacobs, JP; Kasnic, D; et al.
Cardiology in the Young.
2019;
29:111-118.